Carregant...
Use of immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis
Immunosuppressive therapy (IST) is one therapy option for treatment of patients with lower-risk myelodysplastic syndromes (MDS). However, the use of several different immunosuppressive regimens, the lack of high-quality studies, and the absence of validated predictive biomarkers pose important chall...
Guardat en:
| Publicat a: | Haematologica |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ferrata Storti Foundation
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6939518/ https://ncbi.nlm.nih.gov/pubmed/31004015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2019.219345 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|